0001415889-21-004513.txt : 20210921
0001415889-21-004513.hdr.sgml : 20210921
20210921181913
ACCESSION NUMBER: 0001415889-21-004513
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210920
FILED AS OF DATE: 20210921
DATE AS OF CHANGE: 20210921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harmon Cyrus
CENTRAL INDEX KEY: 0001831410
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39712
FILM NUMBER: 211267462
MAIL ADDRESS:
STREET 1: C/O OLEMA PHARMACEUTICALS, INC.
STREET 2: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001750284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 300409740
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (415) 651-3316
MAIL ADDRESS:
STREET 1: 512 2ND STREET, 4TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
form4-09212021_030906.xml
X0306
4
2021-09-20
0001750284
Olema Pharmaceuticals, Inc.
OLMA
0001831410
Harmon Cyrus
C/O OLEMA PHARMACEUTICALS, INC.
512 2ND STREET, 4TH FLOOR
SAN FRANCISCO
CA
94107
true
true
false
false
CHIEF TECHNOLOGY OFFICER
Common Stock
2021-09-20
4
S
0
12000
26.30
D
1063546
D
Common Stock
122028
I
See Footnote
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
The weighted average sale price for the transaction reported was $26.30, and the range of prices were between $25.95 and $26.70. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
The shares are held by the Harmon Family Investors LLC, of which the Reporting Person is the manager.
/s/ John B. Moriarty, Jr., Attorney-in-Fact
2021-09-21